Paclitaxel Injection (30mg)

Listing ID #960513

Get Latest Price

Supply Type Manufacturer, Exporter, Supplier

Preferred Buyer From : All over the world

Paclitaxel Injection (30mg) is manufactured using castor oil that helps in treating ovarian cancer. Our company is second to none in manufacture, supply and export of Paclitaxel Injection....

View More Details

Send Enquiry

Product Details

Paclitaxel Injection (30mg) is manufactured using castor oil that helps in treating ovarian cancer. Our company is second to none in manufacture, supply and export of Paclitaxel Injection (30mg) from Delhi. These Paclitaxel Injection (30mg) are administered once in every three weeks. It is also used in case of head and neck cancer.

Indications :

Primary Indications :
- Breast Cancer
- Cervical Cancer
- Endometrial Cancer
- Lung Cancer
- Kaposi's Carcoma
- Ovarian Cancer
Secondary Indications :
- Bladder Cancer
- Leukemias
- Head & Neck Cancer
- Malignant Melanoma

Dosage :

Primary treatment of Ovarian Cancer : 175mg/m2 IV over a period of 3 hours, followed by Cisplatin 75mg/m2, with a 3 week interval between courses. This should be used at a dose of 135mg/m2, administered IV over 3 hours followed by Cisplatin 75mg/m2. The infusion should be repeated every 3 weeks.
Secondary treatment of Ovarian Cancer and Breast Cancer : 175mg/m2 IV over a period of 3 hours every three weeks. Patients who experience severe neutropenia (neutrophil < 500 cells/mm3) or severe peripheral neuropathy should receive a dosage reduced by 20% for subsequent courses.
Kaposi's sarcoma : 135mg/m2 IV over a period of 3 hours, with a 3 week interval between courses, or, 100mg/m2 IV over a period of 3 hours with a 2 week interval between courses.
Both regimens result in comparable dosing intensity (45-50mg/m2/week).
Primary treatment of NSCLC : 175mg/m2 IV over a period of 3 hours, followed by a platinum compound, with a 3 week interval between courses.

Dosage Adjustment :

Renal Impairment : Not Required.
Hepatic Impairment : Required.

Packing : 30 mg

Company Details

United biotech pvt. Ltd. (ubpl), one of the fastest growing pharmaceutical company in india, was established in 1997. A multi-crore entity, with who-cgmp and iso 9001:2008 certified state-of-the-art manufacturing facility, has strategic tie-ups with several mncs, apart from having one of the most exciting product pipelines in the industry today.
Ubpl embodies a very human spirit by always remaining at the forefront to introduce lifesaving drugs for serving ailing mankind. Over the years, united biotech's name has come to stand for scientific innovation, vision and integrity and is rooted in its founding father's passion for progress. The innovativeness, competitiveness and a will to succeed against all odds are the qualities that are at the heart of ubpl culture. All this synergise with the dream of our founder, who has spent his lifetime in the pursuit of his mission of providing world class speciality healthcare products at affordable costs.
Our quality products today reaches to 55 countries making us a force to reckon with in exports too. Today we are registered in 49 countries and are well poised to make a mark in regulated markets as well.
Marching forward, our dynamic research and development abilities, best in class manufacturing capabilities and sharp marketing acumen, will take us far and ahead. We will continuously benchmark and evaluate ourself in our mission to become a globally acclaimed pharmaceutical company.